Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients
Open Access
- 11 June 1999
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 80 (9), 1453-1458
- https://doi.org/10.1038/sj.bjc.6690543
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancerThe Lancet, 1997
- Prognostic characteristics in breast cancers after hormone replacement therapyBreast Cancer Research and Treatment, 1996
- Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement TherapyObstetrics & Gynecology, 1995
- Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States)Cancer Causes & Control, 1994
- Breast cancer screening with mammography: overview of Swedish randomised trialsThe Lancet, 1993
- Mortality in a cohort of long‐term users of hormone replacement therapy: an updated analysisBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Indicators of Prognosis in Node-Negative Breast CancerNew England Journal of Medicine, 1990
- Enzyme Immunoassay of Progesterone Receptor in Breast Cancer Biopsy Samples A comparison with the dextran coated charcoal methodActa Oncologica, 1989
- Enzyme Immuno Assay of the Estrogen Receptor in Breast Cancer Biopsy Samples a Comparison with Isoelectric FocusingActa Radiologica: Oncology, 1986